Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PV-10 + Pembrolizumab in Metastatic Melanoma
NCT02557321Phase 2Active, not recruiting
- Sponsor
- Provectus Biopharmaceuticals
- Start
- Oct 2015
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PV-10 in melanoma, sponsored by Provectus Biopharmaceuticals. Started Oct 2015; status: active, not recruiting.
02
Drugs
PV-10
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02557321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02557321.